Scientific Program

Filter Results:

Show Only CME Accredited Sessions

  • +

    ISS11 - Symposium Supported by Pfizer: Future Options for ALK+ Metastatic NSCLC (Not IASLC CME Accredited)

    • Moderators:
    • +

      Welcome and Introduction

      07:00 - 08:00  |  Presenting Author(s): Geoffrey Liu

      • Abstract

      Abstract not provided

    • +

      Recent advances in treating ALK+ NSCLC: An evolving landscape

      08:00 - 08:00  |  Presenting Author(s): Ben J Solomon

      • Abstract

      Abstract not provided

    • +

      Navigating the spectrum of resistance mutations in ALK+ NSCLC: How to identify and treat them

      08:00 - 08:00  |  Presenting Author(s): Alice T. Shaw

      • Abstract

      Abstract not provided

    • +

      Panel Q&A

      08:00 - 08:00  |  Presenting Author(s): Geoffrey Liu, Ben J Solomon, Alice T. Shaw

      • Abstract

      Abstract not provided

  • +

    ISS12 - Symposium Supported by Roche: Selecting the Right Cancer Immunotherapy Regimen for the Right Patient in First-line Lung Cancer (Not IASLC CME Accredited)

    • Moderators:
    • +

      Spotlight on cancer immunotherapy: scientific advances and evolving clinical practice in first-line lung cancer

      07:00 - 07:00  |  Author(s): Suresh S. Ramalingam

      • Abstract

      Abstract not provided

    • +

      Optimising treatment for first-line NSCLC

      07:00 - 07:00  |  Presenting Author(s): Vassiliki A Papadimitrakopoulou  |  Author(s): Ross Soo

      • Abstract

      Abstract not provided

    • +

      Putting it all into perspective: what does this mean for our patients?

      07:00 - 07:00  |  Presenting Author(s): Suresh S. Ramalingam, Vassiliki A Papadimitrakopoulou, Ross Soo

      • Abstract

      Abstract not provided

  • +

    ISS13 - Symposium Supported by Medscape: Progress of the NSCLC Revolution: Questioning the Experts (Not IASLC CME Accredited)

    • Moderators:
    • +

      Welcome and Introductions

      07:00 - 07:05  |  Presenting Author(s): Tony S. Mok

      • Abstract

      Abstract not provided

    • +

      Molecular Testing in NSCLC: Where Are We Going?

      07:05 - 07:20  |  Presenting Author(s): Fabrice Barlesi

      • Abstract

      Abstract not provided

    • +

      Treating New Molecular Targets in NSCLC: How Are We Progressing?

      07:20 - 07:35  |  Presenting Author(s): Sanjay Popat

      • Abstract

      Abstract not provided

    • +

      Immunotherapy in NSCLC: Where Have We Got to?

      07:35 - 07:45  |  Presenting Author(s): Edward B Garon

      • Abstract

      Abstract not provided

    • +

      How Are We Doing in the Delivery of the NSCLC Revolution?

      07:45 - 07:57  |  Presenting Author(s): Tony S. Mok, Fabrice Barlesi, Edward B Garon, Sanjay Popat

      • Abstract

      Abstract not provided

  • +

    MTE11 - Biology of Small Cell Lung Cancer (Ticketed Session)

    • Type: Meet the Expert Session
    • Track: Biology
    • Moderators:
    • +

      MTE11.01 - Novel Therapeutic Targets in SCLC

      07:00 - 07:30  |  Presenting Author(s): Julien Sage

      • Abstract

      Abstract not provided

    • +

      MTE11.02 - Biological Subsets of SCLC

      07:30 - 08:00  |  Presenting Author(s): Charles M. Rudin

      • Abstract

      Abstract not provided

  • +

    MTE12 - IO in the Real World - High Risk Populations And Patient Support (Ticketed Session)

    • Type: Meet the Expert Session
    • Track: Immunooncology
    • Moderators:
    • +

      MTE12.01 - Is IO an Option for Patients with Contraindications (Auto-immune Disease, Pulmonary Fibrosis, HIV, Hepatitis, Transplant etc)

      07:00 - 07:40  |  Presenting Author(s): Andrew G Robinson

      • Abstract

      Abstract not provided

    • +

      MTE12.02 - How can we Minimize Toxicity for our High Risk Patients?

      07:40 - 08:00  |  Presenting Author(s): Massey Nematollahi

      • Abstract

      Abstract not provided

  • +

    MTE13 - Clonal Evolution and Targeted Therapy (Ticketed Session)

    • Type: Meet the Expert Session
    • Track: Targeted Therapy
    • Moderators:
    • +

      MTE13.01 - Clonal Evolution and Targeted Therapy

      07:00 - 07:30  |  Presenting Author(s): Ramaswamy Govindan

      • Abstract

      Abstract not provided

    • +

      MTE13.02 - Clonal Evolution and Targeted Therapy

      07:30 - 08:00  |  Presenting Author(s): Janessa Laskin

      • Abstract

      Abstract not provided

  • +

    MTE14 - Nodule Management (Pro Con Debate and Case Presentations) (Ticketed Session)

    • Type: Meet the Expert Session
    • Track: Screening and Early Detection
    • Moderators:
    • +

      MTE14.01 - Nodule Management (Pro Con Debate and Case Presentations)

      07:00 - 08:00  |  Presenting Author(s): Stephen Lam, Matthijs Oudkerk

      • Abstract

      Abstract not provided

  • +

    MTE15 - Who is Too High Risk for a VATS Resection? (Ticketed Session)

    • Type: Meet the Expert Session
    • Track: Treatment of Early Stage/Localized Disease
    • Moderators:
    • +

      MTE15.01 - Identifying High Risk Patients: What Makes a Patient Too High Risk for Surgery and Who Decides?

      07:00 - 07:30  |  Presenting Author(s): Hisao Asamura

      • Abstract

      Abstract not provided

    • +

      MTE15.02 - Who is Too High Risk for a VATS Resection?

      07:30 - 08:00  |  Presenting Author(s): Pieter E. Postmus

      • Abstract

      Abstract not provided

  • +

    MTE16 - What Is Changing in the Management of Pulmonary Neuroendocrine Tumours? (Ticketed Session)

    • Type: Meet the Expert Session
    • Track: Small Cell Lung Cancer/NET
    • Moderators:
    • +

      MTE16.01 - Proper Treatment of LCNEC; Chemotherapy or Targeted Therapy

      07:00 - 07:30  |  Presenting Author(s): Sumitra Thongprasert

      • Abstract

      Abstract not provided

    • +

      MTE16.02 - The Management of Small Cell Lung Cancer following First Line Treatment Failure

      07:30 - 08:00  |  Presenting Author(s): Glenwood Goss

      • Abstract

      Abstract not provided

  • +

    MTE17 - Living with and Beyond Lung Cancer: An Education for Advocates (Ticketed Session)

    • Type: Meet the Expert Session
    • Track: Advocacy
    • Moderators: